WestVac BioPharma Co., Ltd. is an innovative biopharmaceutical enterprise integrating vaccine R&D, production and sales, including WestVac Biopharma located in Chengdu and WestVac Biopharma (Guangzhou), a wholly-owned subsidiary company of WestVac Biopharma. WestVac Biopharma has a mature insect cell expression platform, mRNA vaccine platform, novel adjuvant platform, bacterial vaccine platform, oncology vaccine and immunotherapy platform. It is committed to develop and produce a variety of innovative vaccines and immunotherapy products.

WestVac Biopharma Co., Ltd. is located in in Chengdu Tianfu International Biological City, has completed construction of 5,000-litre and 3,000-litre insect cell recombinant protein vaccine production lines with an annual production capacity of 100 million doses. The GMP production lines were well established with the “Drug Production License" in place. WestVac Biopharma has received the GMP (Good Manufacturing Practice) certificate from the Federal Commission for Protection against Health Risks (COFEPRIS) in Mexico, a member of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S). This certification covers all the COVID-19 vaccines produced by WestVac Biopharma using insect cells (Sf9), including the Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) and other COVID-19 vaccine series. WestVac Biopharma (Guangzhou) is located in Guangzhou Economic Development Zone, has completed scale-up construction of insect cell recombinant protein vaccine production lines with an annual production capacity of 100 million doses.

In terms of production, quality, operations management, etc., WestVac Biopharma has introduced top talents from well-known domestic and international vaccine companies, established a complete production and quality management system, has more than 500 employees to ensure mass production of vaccines can proceed smoothly.

WestVac Biopharma has established a sound communication mechanism with many international organizations such as the World Health Organization (WHO), Bill & Melinda Gates Foundation, PATH, The Coalition for Epidemic Preparedness Innovations (CEPI).

In the future, WestVac Biopharma will grow into a world leading vaccine and immunotherapy platform in line with the corporate philosophy of "We Initiate Science & Technology Value, Always for Caring", seek innovation in the prevention and overcome of human diseases, bring innovative vaccines and immunotherapies from China to the world for the benefit of mankind.